Considerations on the possible origins of fetal hemoglobin cells produced in developing tumors

Stem Cells and Development

Volumn 23, Issue 8, 2014, Pages 791-795

  Wolk, Moshe ^a  

^a MINISTRY OF HEALTH   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; HEMOGLOBIN F; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ARTICLE; BLADDER TUMOR; CARCINOGENESIS; CELL PROLIFERATION; CELL REGENERATION; COLORECTAL TUMOR; EMBRYO DEVELOPMENT; EMBRYONAL CARCINOMA; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; ERYTHROBLAST; ERYTHROCYTE; ERYTHROID CELL; ERYTHROPOIESIS; HEMANGIOBLAST; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; LEUKEMIA; MYELOID LEUKEMIA; ONTOGENY; OXYGEN AFFINITY; POSTNATAL DEVELOPMENT; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; RETINOBLASTOMA; SOLID TUMOR; TUMOR GROWTH; ANIMAL; BIOSYNTHESIS; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANIMALS; ENDOTHELIUM, VASCULAR; ERYTHROBLASTS; FETAL HEMOGLOBIN; HEMATOPOIESIS; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84898724623     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0450     Document Type: Article

References (34)

1. Wolk M, JE Martin, and C Reinus. (2006). Development of fetal hemoglobin-blood cells (F cells) within colorectal tumour tissues. J Clin Pathol 59:598-602.
2. Wolk M, JE Martin, and M Nowicki. (2007). Foetal haemoglobin-blood cells(F-cells) as a feature of embryonic tumours (blastomas) Br J Cancer 97:412-419.
3. Wolk M and JE Martin. (2012). Fetal haemoglobin marking low grade urinary bladder cancer. Br J Cancer 107:477-481.
4. Wolk M, AC Newland, B de la Salle, M Peleg, and G Brufman. (1999). Refinement of plasma fetal hemoglobin measurements, as related to whole blood HbF, in cancer. J Tumor Marker Oncol 14:115-126.
5. Zambidis ET, B Peault, TS Park, F Bunz, and CI Civin. (2005). Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definite stages resembling human yolk sac development. Blood 106:860-870.
6. Lancrin C, P Sorzynska, C Stephenson, T Allen, V Kouskoff, and G Lacaud. (2009). The haemangioblast generates haematopoietic cells through a haemogenic endothelial stage. Nature 457:8920895.
7. Sluvkin II. (2013). Deciphering the hierarchy of angiohematopoietic progenitors from human pluripotent stem cells. Cell Cycle 12:720-727.
8. Folkman J. (1971). Tumor angiogenesis: therapeutic implications. N Engl J Med 285:1182-1186.
9. Gimbrone, MA, Jr., SB Leapman, RS Cotran, and J Folkman. (1972). Tumor dormancy in vivo by prevention of neovascularization. J Exp Med 136:261-276.
10. Naumov GN, LA Akslen, and J Folkman. (2006). Role of angiogenesis in human tumor dormancy. Cell Cycle 5: 1779-1787.
11. Folkman J. (2003). Fundamental conceptus of the angiogenic process. Curr Mol Med 3:643-651.
12. Wu HC, CT Huang, and DK Chang. (2008). Anti-angiogenic therapeutic drugs for treatment of human cancer. J Cancer Mol 4:37-45.
13. Bloom W and GW Bartelmez. (1940). Hematopoiesis in young human embryos. Am J Anat 67:21-53.
14. Medvinski A, S Rybtsov, and S Taoud. (2011). Embryonic origin of adult hematopoietic system: advances and questions. Development 138:1017-1031.
15. Palis J, S Robertson, M Kemnedy, C Wall, and G Keller. (1999). Development of erythroid and myeloid progenitors in the yolk sac and embryo proper of the mouse. Development 125:5073-50874.
16. Peschle C, F Mavilio, A Care, G Migiliaccio, G Salvo, P Samoggia, S Petti, R Gueiero, and M Marinucci. (1985). Haemoglobin switching in human embryos: asynchrony of zeta-alpha and epsilon-gamma-globin switches in primitive and definite erythropoietic lineage. Nature 313:235-238.
17. Migiliaccio G, AR Migiliaccio, S Petti, F Mavilio, G Russo, D Lazzaro, U Testa, M Marinucci, and C Peschle. (1986). Human embryonic hemoipoiesis. J Clin Invest 78:51-60.
18. Ferkowicz MJ and MC Yoder. (2005). Blood island formation: longstanding observations and modern interpretations. Exp Hematol 33:1041-1047.
19. Kinder SJ, TE Tsang, GA Quinlan, AK Hadjantonakis, A Nagy, and PP Tam. (1999). The orderly allocation of mesodermal cells to the extraembryonic structures and the anteroposterior axis during gastrulation of the mouse embryo. Development 126:4691-4701.
20. Dantschakoff V. (1907). Uber das erate auftreten der blutelemente in huhnerembryo. Folla Haematol 4:159-166.
21. Jokubaitis VJ, L Sinka, R Dreissen, G Whitty, DN Haylock, I Bertoncello, I Smith, B Peault, M Tavian, and PJ Simmons. (2008). Angiotensin-converting enzyme (CD 143) marks hematopoietic stem cells in human embryonic, fetal, and adult hematopoietic tissues. Blood 111:4055-4063.
22. Fraser ST, M Ogawa, T Yokomizo, Y Ito, and S Nishikawa. (2003). Putative intermediate precursor between hematogenic endothelial cells and blood cells in the developing embryo. Dev Growth Differ 45:63-75.
23. Bohmer RM. (2004). Erythropoiesis from adult but not fetal blood-derived CD133 + stem cells depends strongly on interleukin-3. Growth Factors 22:45-50.
24. Hirschi KK. (2012). Hemogenic endothelium during development and beyond. Blood 119:4823-4827.
25. Furuta C, H Ema, S Takayanagi, T Ogaeri, D Okamura, Y Matusui, and H Nakauchi. (2006). Discordant development waves of angioblasts and hemangioblasts in the early gastrulation mouse embryo. Development 133:2771-2779.
26. Nadin BM, MA Goodell, and KK Hirschi. (2003). Phenotype and hematopoietic potential of side population cells throughout embryonic development. Blood 102:2436-2443.
27. Sankaran VG and DG Nathan. (2010). Reversing the hemoglobin switch. N Engl J Med 363:2258-2260.
28. Wolk M and JE Martin. (2011). Fetal haemoglobin (HbF) as an immunohistochemical tumour marker in bone marrow and spleen. J Clin Pathol 64:645-647.
29. Lyden D, K Hattori, S Dias, C Costa, P Blaikie, L Butros, A Chadbrun, B Heissig, W Marks, et al. (2001). Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 7:1194-1201.
30. Yasuda S, M Sho, I Yamato, H Yoshiji, K Wakatsuki, S Nishiwada, H Yagita, and Y Nakajuma. (2013). Simultaneous blockade of programmed death1 and vascular endothelium growth factor receptor2 (VEGFR2) induces synergistic anti-tumour effect in vivo. Clin Exp Immunol 172:500-506.
31. Zhang Y, K Kobayashi, K Kitazawa, K Imai, and M Kobayashi. (2006). Contribution of cooperativity and the Bohr effect to efficient oxygen transport by hemoglobin from five mammalian species. Zool Sci 23:49-55.
32. Manca L and B Masala. (2008). Disorder of the synthesis of human fetal hemoglobin. Iubmb Life 60:94-111.
33. Wells RMG and T Brittain. (1981). Transition to cooperative oxygen-binding by embryonic haemoglobin in mice. J Exp Biol 90:351-355.
34. Zhang S, I Mercado-Uribe, and J Liu. (2013). Generation of erythroid cells from fibroblasts and cancer cells in vitro and in vivo. Caner Lett 333:205-212.